These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 215956)

  • 1. [Lipid metabolism disorders in kidney failure].
    Romics L; Makó J
    Orv Hetil; 1978 Dec; 119(50):3055-8. PubMed ID: 215956
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal fat metabolism in chronic renal failure.
    Romics L; Makó J
    Acta Med Acad Sci Hung; 1978; 35(3-4):233-40. PubMed ID: 227218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid and lipoprotein metabolism in chronic kidney disease.
    Kaysen GA
    J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein profile in dialysis and transplant patients.
    Lau YK; Woo KT; Lim CH
    Singapore Med J; 1985 Apr; 26(2):193-7. PubMed ID: 3898396
    [No Abstract]   [Full Text] [Related]  

  • 5. [High-density-lipoprotein and renal insufficiency (author's transl)].
    Graf H; Stummvoll HK; Müller MM
    Wien Klin Wochenschr; 1982 Jan; 94(2):39-41. PubMed ID: 7080495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior of important serum lipid fractions in chronic hemodialysis patients and following kidney transplantation].
    Luci V; Wichmann T; Giesselmann M; Koall W; Mampel E
    Z Gesamte Inn Med; 1983 Mar; 38(5):153-7. PubMed ID: 6344469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients.
    Chen ST; Ferng SH; Yang CS; Peng SJ; Lee HR; Chen JR
    Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
    Gillett MP; Obineche EN; Khan ST; Abdulle AM
    Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary risk in patients with endstage renal disease: interaction of hypertension with hyperlipidemia.
    Goldberg AP; Tindira C; Harter HR
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S257-61. PubMed ID: 6177969
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperlipidemia in rats with chronic renal failure].
    Nikiforova NV; Tananaeva IK; Pozdniakov AL; Sokolovskaia IV
    Biull Eksp Biol Med; 1978 Jun; 85(6):676-9. PubMed ID: 208685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV].
    Romics L; Karádi I; Simonyi E
    Orv Hetil; 1980 Oct; 121(43):2629-31. PubMed ID: 7208011
    [No Abstract]   [Full Text] [Related]  

  • 12. [Lipid metabolism disorders in chronic kidney failure].
    Lacour B; Roullet JB; Drueke T
    Nephrologie; 1983; 4(2):75-83. PubMed ID: 6348572
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dyslipidemia characteristics in arterial hypertension].
    Neverov IV; Baĭmatova DD
    Sov Med; 1984; (6):46-9. PubMed ID: 6379903
    [No Abstract]   [Full Text] [Related]  

  • 14. Improved lipid profiles with bicarbonate dialysis.
    Ahmad S; Haas L; Pagel M; Sherrard D
    Proc Clin Dial Transplant Forum; 1980; 10():186-9. PubMed ID: 7346846
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in serum lipid and lipoprotein levels in patients with chronic uremia during hemodialysis treatment].
    László A; Csalánosiné Németh M; Joó I; Kiss E; Havass Z; Szenohradszki P
    Orv Hetil; 1986 May; 127(19):1129-31. PubMed ID: 3714258
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in HDL-cholesterol, subfractions HDL2 and HDL3 and apo-A, apo-A1 and apo-B lipoproteins in patients with chronic renal failure subjected to maintenance hemodialysis].
    Scarazatti E; Garavaglia G
    Boll Soc Ital Biol Sper; 1985 Jan; 61(1):15-21. PubMed ID: 3977994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P; Kannan NK
    J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperlipidemia in patients with chronic renal failure.
    Ravichandran R; Nerurkar SV; Acharya VN; Taskar SP
    J Postgrad Med; 1983 Oct; 29(4):212-7. PubMed ID: 6672179
    [No Abstract]   [Full Text] [Related]  

  • 19. Classification of lipid disorders in chronic hemodialyzed patients.
    Król E; Rutkowski B; Wróblewska M; Badzio T
    Miner Electrolyte Metab; 1996; 22(1-3):13-5. PubMed ID: 8676804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo development of hypercholesterolaemia and increased HDL-cholesterol: apoprotein A-I ratio in patients with chronic renal failure following kidney transplantation.
    Kobayashi N; Okubo M; Marumo F
    Proc Eur Dial Transplant Assoc; 1983; 19():505-9. PubMed ID: 6410382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.